Link to this page
PMO Precision Medicine Ontology
Last uploaded:
December 16, 2020
Jump to:
Preferred Name | Efalizumab | |
Synonyms |
|
|
ID |
http://www.phoc.org.cn/pmo/class/PMO_00026140 |
|
Database_Cross_Reference |
NCI:C68831 MMSL:17649 DRUGBANK:DB00095 NCI_NCI-GLOSS:CDR0000559446 MMSL:d04902 NCI_FDA:XX2MN88N5D NDFRT:N0000148826 SNOMEDCT_US:407006005 MSH:C472181 MEDCIN:258861 NDDF:005208 NDFRT:N0000010343 SNOMEDCT_US:407005009 ATC:L04AA21 VANDF:4021411 RXNORM:356988
|
|
label |
Efalizumab
|
|
MCID |
MC00400119
|
|
PMOID |
PMO:00026140
|
|
prefixIRI |
pmo:PMO_00026140
|
|
prefLabel |
Efalizumab
|
|
Synonym |
anti alphaL integrin efalizumab EFALIZUMAB efalizumab [Chemical/Ingredient] Efalizumab (substance) efalizumab (medication) antiCD11 alpha Efalizumab (product)
|
|
Tree Number |
T6.4.4.2.5.3
|
|
subClassOf |
Add comment
Delete | Subject | Author | Type | Created |
---|---|---|---|---|
No notes to display |
Create mapping